Biotech Values

[mouton29]

The order:

-1-
United States District Court
District of Massachusetts
________________________________
MOMENTA PHARMS., INC., SANDOZ
INC.,
Plaintiffs,
v.
AMPHASTAR PHARMS., INC.,
INTERNATIONAL MEDICATION SYS.,
LTD., WATSON PHARMS., INC.,
Defendants.
________________________________
)
)
)
)
) Civil Action No.
) 11-11681-NMG
)
)
)
)
)
)
PRELIMINARY INJUNCTION
GORTON, J.
For the reasons set forth in this Court’s Memorandum and Order
entered herewith, it is hereby ORDERED, ADJUDGED AND DECREED that
from the date of this Order until the conclusion of the trial in
this action, unless otherwise ordered by the Court:
1) defendants Amphastar Pharmaceuticals, Inc., International
Medication Systems, Ltd. and Watson Pharmaceuticals,
Inc., and any entity or persons acting on their behalf,
shall not advertise, offer for sale or sell in the United
States any generic enoxaparin product alleged to infringe
U.S. Patent No. 7,575,886; and
2) plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc.,
pursuant to Fed. R. Civ. P. 65(c), shall post a security
bond in the amount of One Hundred Million Dollars
($100,000,000) as soon as reasonably practicable after
entry of this Order but in any event no later than close
of business November 13, 2011.
So ordered.
/s/ Nathaniel M. Gorton
Nathaniel M. Gorton
United States District Judge
Dated October 28, 2011
Case 1:11-cv-11681-NMG Document 93 Filed 10/28/11 Page 1 of 1